Pfizer, Inc. Share Price

Equities

PFE

US7170811035

Pharmaceuticals

Real-time Estimate Cboe BZX 19:55:38 22/04/2024 BST 5-day change 1st Jan Change
26.44 USD +1.67% Intraday chart for Pfizer, Inc. +2.01% -8.20%
Sales 2024 * 59.95B 4,852B Sales 2025 * 62.56B 5,063B Capitalization 147B 11,915B
Net income 2024 * 6.92B 560B Net income 2025 * 9.43B 763B EV / Sales 2024 * 3.24 x
Net Debt 2024 * 47.04B 3,807B Net Debt 2025 * 41.91B 3,392B EV / Sales 2025 * 3.02 x
P/E ratio 2024 *
18.8 x
P/E ratio 2025 *
13.8 x
Employees 88,000
Yield 2024 *
6.52%
Yield 2025 *
6.69%
Free-Float 59.09%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.83%
1 week+2.22%
Current month-4.56%
1 month-3.20%
3 months-6.45%
6 months-14.12%
Current year-8.01%
More quotes
1 week
25.23
Extreme 25.23
26.50
1 month
25.23
Extreme 25.23
28.12
Current year
25.23
Extreme 25.23
30.28
1 year
25.23
Extreme 25.23
40.37
3 years
25.23
Extreme 25.23
61.71
5 years
25.23
Extreme 25.23
61.71
10 years
25.23
Extreme 25.23
61.71
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 31/12/92
Director of Finance/CFO 59 01/05/22
Chief Tech/Sci/R&D Officer - 30/06/19
Members of the board TitleAgeSince
Director/Board Member 66 31/03/20
Director/Board Member 64 22/02/17
Director/Board Member 60 26/09/13
More insiders
Date Price Change Volume
22/04/24 26.42 +1.63% 20 961 613
19/04/24 26 +2.40% 38,372,801
18/04/24 25.39 -0.12% 35,788,351
17/04/24 25.42 -1.05% 43,828,892
16/04/24 25.69 -0.85% 28,885,313

Delayed Quote Nyse, April 22, 2024 at 07:15 pm

More quotes
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
26 USD
Average target price
31.62 USD
Spread / Average Target
+21.62%
Consensus